Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
0.7011
+0.0280 (4.16%)
At close: May 22, 2026, 4:00 PM EDT
0.6905
-0.0106 (-1.51%)
After-hours: May 22, 2026, 7:59 PM EDT

Citius Pharmaceuticals Income Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Cost of Revenue
1.12-----
Gross Profit
4.49-----
Selling, General & Admin
54.1429.3730.0921.9115.6611.29
Depreciation & Amortization Expenses
2.29-----
Research & Development
6.59.1611.9114.8217.6612.24
Total Operating Expenses
62.9338.534236.7333.3223.53
Operating Income
-58.44-38.53-42-36.73-33.32-23.53
Interest Income
0.170.110.761.180.250.26
Interest Expense
-0.46-0.27----0.01
Other Non-Operating Income (Expense)
3.83-2.393.59-0.23
Total Non-Operating Income (Expense)
3.49-0.163.154.770.250.48
Pretax Income
-54.89-38.68-38.85-31.97-33.06-23.05
Provision for Income Taxes
0.561.060.580.580.58-
Net Income
-46.2-37.43-40.19-33.69-33.64-24.51
Minority Interest in Earnings
-9.25-2.31-0.29---
Net Income Attributable to Preferred Dividends
---1.05-1.15-1.45
Net Income to Common
-46.2-37.43-40.19-33.69-33.64-24.51
Shares Outstanding (Basic)
18117664
Shares Outstanding (Diluted)
18117664
Shares Change (YoY)
138.18%64.49%11.16%3.57%34.52%177.28%
EPS (Basic)
-2.24-3.38-5.97-5.57-5.75-5.75
EPS (Diluted)
-2.24-3.38-5.97-5.57-5.75-5.75
Shares Outstanding
22.3818.077.256.355.855.84
Free Cash Flow
-31.6-26.55-28.2-29.06-28.36-24.26
Free Cash Flow Per Share
-1.75-2.40-4.19-4.80-4.85-5.58
EBITDA
-56.02-38.31-41.79-36.54-33.14-23.37
EBIT
-58.44-38.53-42-36.73-33.32-23.53
Effective Tax Rate
-1.02%-2.73%-1.48%-1.80%-1.74%0.00%
Updated May 15, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q